International HIT-MED Registry

Author:  Julia Dobke, Last modification: 2024/09/19 https://kinderkrebsinfo.de/doi/e142890

International HIT-MED Registry International HIT-MED Registry (I-HIT-MED): For children, adolescents and adults with medulloblastoma, ependymal, pineal, or choroid plexus tumours
Disease Medulloblastoma, Ependymoma, pineal, or choroid plexus tumours
Type Registry
Therapy / Study arms

The I-HIT-MED Registry collects clinical information of children and adults with an initial diagnosis or relapse of medulloblastoma, ependymal, pineal, and choroid plexus tumours in Germany and other countries that fulfil national ethic requirements for participation in this registry. These tumours are rare diseases and for many patients, clinical trials are unavailable at the time of their diagnosis. Therefore, these patients are treated according to established standard of care protocols. The I-HIT-MED Registry collects clinical and biological data from those patients as well as long-term outcome data.
Inclusion Criteria
  • Children and adults with histologically proven: Medulloblastoma (all subtypes), Ependymal tumours (all subtypes), Pineal tumours (all subtypes), patients with choroid plexus tumours according to the revised 5ᵗʰ edition of the WHO-classifications, 2021
  • first diagnosis after 01.01.2012
  • all clinical stages
  • any localization of the primary tumour or not known primary localization
  • Consent to share biological materials not used during routine diagnostics
  • Consent to participate in biological accompanying studies
  • Consent to additional biological investigations
Exclusion Criteria
  • Lack of valid ethical committee approval
  • Treatment in a centre or region where provision of biological material and / or its data is impossible
Status start: 01.01.2015, end of recruitment: 31.12.2034
Principal Investigator Prof. Dr. med. Stefan Rutkowski
E-Mail hitchem@uke.de
URL https://www.uke.de/kliniken-institute/kliniken/p%C3%A4diatrische-h%C3%A4matologie-und-onkologie/forschung/arbeitsgruppen/hit-studien.html
Contact

International Coordinator

Prof. Dr. med. Stefan Rutkowski Universitätsklinikum Hamburg-Eppendorf Klinik u. Poliklinik f. Päd. Onkologie u. Hämatologie, Haus N21 Martinistr. 52 20246 Hamburg Telefon +49 (40) 7410 58200 Fax +49 (40) 7410 58300 s.rutkowski@uke.de

Senior Associate Investigator

PD Dr. med. Martin Mynarek Universitätsklinikum Hamburg-Eppendorf Klinik für Pädiatrische Hämatologie und Onkologie Martinistr. 52 20246 Hamburg Telefon +49 (0)40 74 10-5 33 94 m.mynarek@uke.de

Clinical Trial Manger

Regine Riechers Universitätsklinikum Hamburg-Eppendorf Klinik für Pädiatrische Hämatologie und Onkologie Martinistr. 52 20246 Hamburg Telefon +49 (0)40 74 10-567 76 Fax +49 (0)40 74 10-5 83 00 r.riechers@uke.de

Data Manager

Susanne Becker Uni­ver­si­täts­kli­ni­kum Ham­burg-Ep­pen­dorf Kli­nik u. Po­li­kli­nik f. Päd. On­ko­lo­gie u. Hä­ma­to­lo­gie, Haus N21, HIT-MED Studienzentrale Martinistr. 52 20246 Ham­burg Telefon +49 (40) 7410 58200 Fax +49 (40) 7410 58300 hitchem@uke.de

Antje Stiegmann Universitätsklinikum Hamburg-Eppendorf Kli­nik u. Po­li­kli­nik f. Päd. On­ko­lo­gie u. Hä­ma­to­lo­gie, Haus N21, HIT-MED Stu­di­en­zen­tra­le Martinistr. 52 20246 Hamburg Telefon +49 (40) 7410 58200 Fax +49 (40) 7410 58300 hitchem@uke.de

Participants Deutschland, Östereich, Schweiz
Link(s) Publications
Sponsoring Deutsche Kinderkrebsstiftung, Damp-Stiftung, Fördergemeinschaft Kinderkrebszentrum Hamburg